Results 151 to 160 of about 67,279 (165)
Some of the next articles are maybe not open access.
Role of interferons in demyelinating disease
1997Interferon beta 1b (Betaseron) was licensed by the U.S. Federal Food and Drug Administration in July 1993 as the first treatment to alter the natural history of multiple sclerosis (MS). The drug, injected subcutaneously every other day, reduced the frequency of relapses and the expansion of central white matter pathology as measured by MRI.
openaire +3 more sources
The pathogenesis of demyelinating disease
Progress in Neurobiology, 1994N.J. Scolding +3 more
openaire +3 more sources
THE DIFFUSE DEMYELINATING DISEASES
Developmental Medicine & Child Neurology, 1965openaire +3 more sources